{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"69"}],"units":"Participants"}],"description":"Atezolizumab was administered on Day 1 only for a cycle duration of 3 weeks.","groups":[{"description":"Participants \\<18 Age (Years)","id":"OG000","title":"<18 Age (Years)"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"From baseline up to approximately 42 months","title":"Optimal Dose of Atezolizumab in Pediatric Adult Participants","type":"SECONDARY","unitOfMeasure":"mg/kg"}